Altimmune, Inc.
ALT
Rank in Stocks
#13140
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on... Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted the Altimmune, Inc. moniker in September 2015. Established in 1997, the company maintains its corporate headquarters in Gaithersburg, Maryland.
Share Price
$2.12
Last synced: 2026-11-09
Market Cap
$412.38M
Change (1 day)
1.92%
Change (1 year)
-50.47%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Altimmune, Inc. (ALT)
Category
Healthcare
Dividend history for Altimmune, Inc. (ALT)
Altimmune, Inc. (stock symbol: ALT) made a total of 2 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $1.75K
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $1.75K
Dividend yield (TTM) : 0.00%
Dividend payments for Altimmune, Inc. (ALT) from 2017 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $1,746.01 | 0.00% |
| 2017 | $1,746.01 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $582.00 | 0.00% |
| 2017 | $582.00 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
